LEMAITRE VASCULAR INC (LMAT) › Cash & EquivalentsLEMAITRE VASCULAR INC (LMAT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $15.89M2009: $23.19M2010: $22.61M2011: $20.13M2012: $16.45M2013: $14.71M2014: $18.69M2015: $27.45M2016: $24.29M2017: $19.10M2018: $26.32M2019: $11.79M2020: $26.76M2021: $13.86M2022: $19.13M2023: $24.27M2024: $25.61M2025: $28.24M$28.24M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$28.24M+10.3%2024$25.61M+5.5%2023$24.27M+26.8%2022$19.13M+38.1%2021$13.86M-48.2%2020$26.76M+127.1%2019$11.79M-55.2%2018$26.32M+37.8%2017$19.10M-21.4%2016$24.29M-11.5%2015$27.45M+46.9%2014$18.69M+27.1%2013$14.71M-10.6%2012$16.45M-18.3%2011$20.13M-11.0%2010$22.61M-2.5%2009$23.19M+45.9%2008$15.89M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share